Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Jaw Diseases

fluorodeoxyglucose f18 has been researched along with Jaw Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borzì, G; Frasca, F; Gullo, D; Ilenia, M; Malandrino, P; Russo, M1
Frerich, B; Hemprich, A; Kluge, R; Sabri, O; Schulz, T; Steinhoff, K; Wilde, F; Winter, K1
Arce, K; Assael, LA; Markiewicz, MR; Weissman, JL1
Califano, C; Caparrotti, G; Catalano, L; Del Vecchio, S; Fonti, R; Martorelli, C; Pace, L; Petruzziello, F; Rotoli, B; Salvatore, B; Segreto, S1
Anderson, KC; Chhetri, S; Connell, B; Hande, K; Hideshima, T; Munshi, NC; Raje, N; Richardson, PG; Schlossman, RL; Sheehy, N; Szot-Barnes, A; Tai, YT; Tian, M; Treister, N; Vallet, S; Van Den Abbeele, AD; Weller, E; Woo, SB; Xie, W; Yap, JT1

Reviews

1 review(s) available for fluorodeoxyglucose f18 and Jaw Diseases

ArticleYear
Imaging findings in bisphosphonate-related osteonecrosis of jaws.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2009, Volume: 67, Issue:5 Suppl

    Topics: Bone Density Conservation Agents; Diphosphonates; Fluorodeoxyglucose F18; Humans; Jaw Diseases; Magnetic Resonance Imaging; Osteonecrosis; Positron-Emission Tomography; Radiography, Panoramic; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed

2009

Trials

1 trial(s) available for fluorodeoxyglucose f18 and Jaw Diseases

ArticleYear
Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis.
    Annals of hematology, 2007, Volume: 86, Issue:6

    Topics: Aged; Diphosphonates; Fluorodeoxyglucose F18; Humans; Jaw Diseases; Multiple Myeloma; Osteonecrosis; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi

2007

Other Studies

3 other study(ies) available for fluorodeoxyglucose f18 and Jaw Diseases

ArticleYear
Challenges in the treatment of parathyroid carcinoma: a case report.
    Hormones (Athens, Greece), 2019, Volume: 18, Issue:3

    Topics: Adult; Bone Neoplasms; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hyperparathyroidism, Primary; Jaw Diseases; Neoplasms, Multiple Primary; Osteolysis; Parathyroid Neoplasms; Positron Emission Tomography Computed Tomography; Severity of Illness Index; Thyroid Cancer, Papillary; Thyroid Neoplasms

2019
Positron-emission tomography imaging in the diagnosis of bisphosphonate-related osteonecrosis of the jaw.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2009, Volume: 107, Issue:3

    Topics: Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Imidazoles; Jaw Diseases; Male; Osteonecrosis; Positron-Emission Tomography; Radiopharmaceuticals; Zoledronic Acid

2009
Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Apr-15, Volume: 14, Issue:8

    Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Remodeling; Diphosphonates; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Jaw Diseases; Male; Middle Aged; Multiple Myeloma; Osteogenesis; Osteonecrosis; Positron-Emission Tomography

2008